Trials / Completed
CompletedNCT01371435
Drug Use Investigation for PAXIL Tablet
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,708 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
This post-marketing surveillance study is designed to detect adverse events (particularly clinically significant adverse drug reactions) occurring in clinical settings and to examine factors likely to affect the safety and efficacy of paroxetine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Paroxetine |
Timeline
- Start date
- 2001-04-01
- Primary completion
- 2005-09-01
- Completion
- 2005-12-01
- First posted
- 2011-06-10
- Last updated
- 2017-06-08
Source: ClinicalTrials.gov record NCT01371435. Inclusion in this directory is not an endorsement.